asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21–dependent mechanism

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta… - Circulation …, 2010 - Am Heart Assoc
Rationale: The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine
(ADMA) is increased in patients with coronary artery disease and may regulate function of …

asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism

F Fleissner, V Jazbutyte, J Fiedler… - Circulation …, 2010 - pubmed.ncbi.nlm.nih.gov
Rationale The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine
(ADMA) is increased in patients with coronary artery disease and may regulate function of …

Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta… - Circulation …, 2010 - kclpure.kcl.ac.uk
Rationale: The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine
(ADMA) is increased in patients with coronary artery disease and may regulate function of …

Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a MicroRNA-21-Dependent mechanism

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta… - Circulation …, 2010 - elibrary.ru
Rationale: The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine
(ADMA) is increased in patients with coronary artery disease and may regulate function of …

Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta, X Yin… - Circulation …, 2010 - cir.nii.ac.jp
< jats: p>< jats: bold>< jats: italic>< jats: underline> Rationale</jats: underline>:</jats:
italic></jats: bold> The endogenous nitric oxide synthase inhibitor asymmetrical …

asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism.

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta… - Circulation …, 2010 - europepmc.org
Methods and results By using microarray analyses, we established microRNA expression
profiles of human APCs. We used ADMA to induce APC dysfunction and found 16 …

Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21-Dependent Mechanism

F Fleissner, V Jazbutyte, J Fiedler, SK Gupta… - Circulation …, 2010 - hero.epa.gov
Rationale: The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine
(ADMA) is increased in patients with coronary artery disease and may regulate function of …

[引用][C] Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21-Dependent …

F FLEISSNER, V JAZBUTYTE… - Circulation …, 2010 - pascal-francis.inist.fr
Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With
Coronary Artery Disease Through a MicroRNA-21-Dependent Mechanism CNRS Inist …

[引用][C] Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21-Dependent …

F FLEISSNER, V JAZBUTYTE… - Circulation …, 2010 - Lippincott Williams & Wilkins